Structural Genomics Consortium is a biotechnology company based out of 101 College St Suite 700, Toronto, ON, Canada.
| Website | http://www.uhnres.utoronto.ca |
| Revenue | $1.1 billion |
| Employees | 11 (3 on RocketReach) |
| Address | 610 University Avenue, Toronto, Ontario M5G 2M9, CA |
| Phone | +1 416-946-2000 |
| Industry | Biotechnology Research, Hospitals & Clinics, Healthcare |
| Keywords | Biotechnology, Protein Structure, Drug Development, Drug Discovery, Genomics, Structure-Based Drug Design, Medicinal Chemistry, Pharmaceutical Research, Target Identification, Proteomics, Target Validation, Molecular Biology, Small Molecule Inhibitors, Lead Optimization, Chemical Biology, Collaborative Research, High Throughput Screening, Open Science, Assay Development, Academic Research |
| Competitors | Harvard University, Cleveland Clinic, Mayo Clinic, UC San Diego Health, University of California, San Francisco, Massachusetts Institute of Technology, The National Institutes of Health, Broad Institute of MIT and Harvard, Scripps Research, Max Planck Institute for Demographic Research +43 more (view full list) |
Looking for a particular Structural Genomics Consortium employee's phone or email?
The Structural Genomics Consortium annual revenue was $1.1 billion in 2026.
Greg Brothers is the Business Director of Structural Genomics Consortium.
3 people are employed at Structural Genomics Consortium.
Structural Genomics Consortium is based in Toronto, Ontario.